InvestorsHub Logo
Followers 12
Posts 536
Boards Moderated 0
Alias Born 09/08/2014

Re: Cardiologymd post# 297069

Monday, 09/07/2020 9:59:17 AM

Monday, September 07, 2020 9:59:17 AM

Post# of 429660
The article definitely has me thinking about buying some more shares. We’ll be spending lots of dollars battling generics on infringement. Hope we hire a skilled firm, one that knows a cropped table when they see it. If only the FDA would modify the Orange Book to reflect "therapeutic equivalence" coding. That would legitimize "skinny labeling" and protect our share of the market. What are the chances?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News